UK blue chip medical devices company Smith & Nephew has rejected a £7bn takeover bid by its US counterpart Johnson & Johnson.
Johnson and Johnson is thought to have bid 750p per share for Smith & Nephew – the London headquartered FTSE 100 company which specializes in hip and knee replacements and employs just shy of 10,000 people globally. Analysts said Smith & Nephew’s true value could stand at over £10bn and that Johnson & Johnson –…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
